Genie L. Bailey

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Barbara R. Haight, Susan M. Learned, Céline M. Laffont et al. · The Lancet · 2019 · 268 citations

Opioid Epidemic, Substance Use, Psychiatry +7

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

Michelle R. Lofwall, Sharon Walsh, Edward V. Nunes et al. · JAMA Internal Medicine · 2018 · 232 citations · Full text

Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder

Michael D. Stein, Micah T. Conti, Shannon R. Kenney et al. · Drug and Alcohol Dependence · 2017 · 208 citations · Full text

Opioid Epidemic, Substance Abuse, Substance Use +14

Buprenorphine Implants for Treatment of Opioid Dependence

Walter Ling, Paul Casadonte, George E. Bigelow et al. · JAMA · 2010 · 170 citations